BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 23, 15:49Prev. Close
91.38
Open Price
89.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Par Drugs & Chemicals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||||
| SHAREHOLDER'S FUNDS | |||||
| Equity Share Capital | 2.70 | 2.70 | 2.70 | 2.70 | |
| Total Share Capital | 8.45 | 8.45 | 8.45 | 8.45 | |
| Reserves and Surplus | 8.58 | 7.71 | 6.98 | 6.08 | |
| Total Reserves and Surplus | 8.58 | 7.71 | 6.98 | 6.08 | |
| Total Shareholders Funds | 17.03 | 16.16 | 15.43 | 14.53 | |
| NON-CURRENT LIABILITIES | |||||
| Long Term Borrowings | 20.94 | 25.41 | 28.54 | 7.40 | |
| Deferred Tax Liabilities [Net] | 1.63 | 1.53 | 1.29 | 1.12 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 22.58 | 26.94 | 29.83 | 8.52 | |
| CURRENT LIABILITIES | |||||
| Short Term Borrowings | 6.86 | 7.84 | 3.54 | 2.92 | |
| Trade Payables | 6.57 | 4.62 | 3.23 | 2.04 | |
| Other Current Liabilities | 5.08 | 5.36 | 0.23 | 0.33 | |
| Short Term Provisions | 0.48 | 0.47 | 0.42 | 0.45 | |
| Total Current Liabilities | 18.99 | 18.29 | 7.41 | 5.74 | |
| Total Capital And Liabilities | 58.59 | 61.39 | 52.67 | 28.79 | |
| ASSETS | |||||
| NON-CURRENT ASSETS | |||||
| Tangible Assets | 45.11 | 47.06 | 43.03 | 13.73 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 6.20 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 45.11 | 47.06 | 43.03 | 19.93 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.65 | 0.63 | 0.17 | 0.22 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 45.75 | 47.69 | 43.20 | 20.15 | |
| CURRENT ASSETS | |||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 3.97 | 3.49 | 3.45 | 3.67 | |
| Trade Receivables | 7.52 | 7.76 | 3.74 | 3.44 | |
| Cash And Cash Equivalents | 0.03 | 0.73 | 0.03 | 0.08 | |
| Short Term Loans And Advances | 0.50 | 0.48 | 0.49 | 0.68 | |
| OtherCurrentAssets | 0.82 | 1.24 | 1.76 | 0.78 | |
| Total Current Assets | 12.84 | 13.70 | 9.47 | 8.64 | |
| Total Assets | 58.59 | 61.39 | 52.67 | 28.79 | |
| OTHER ADDITIONAL INFORMATION | |||||
| CONTINGENT LIABILITIES, COMMITMENTS | |||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | |||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||||
| Expenditure In Foreign Currency | 0.02 | 0.07 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||||
| FOB Value Of Goods | 4.37 | 3.50 | -- | -- | |
| Other Earnings | -- | -- | 3.17 | 4.53 | |
| BONUS DETAILS | |||||
| Bonus Equity Share Capital | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | |||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | |||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017